MAPT | Microtubule-associated protein tau | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/151/ihc_cell_selected_60x60.jpg) | ![](/images/151/2562_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
MB | Myoglobin | Candidate cardiovascular disease genes Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/60/1942_B_9_4_rna_selected_60x60.jpg) | Group enriched |
MBP | Myelin basic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | ![](/images/49222/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2300/6023_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/13/117_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images/348/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/63909/152372_A_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
MPO | Myeloperoxidase | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21147/146570_B_7_6_rna_selected_60x60.jpg) | Tissue enriched |
MYH11 | Myosin, heavy chain 11, smooth muscle | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | ![](/images/15310/ihc_cell_selected_60x60.jpg) | ![](/images/15310/36931_B_2_3_rna_selected_60x60.jpg) | Mixed |
MYH6 | Myosin, heavy chain 6, cardiac muscle, alpha | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/1239/3034_A_3_4_rna_selected_60x60.jpg) | Tissue enriched |
MYH7 | Myosin, heavy chain 7, cardiac muscle, beta | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | ![](/images/15384/ihc_cell_selected_60x60.jpg) | ![](/images/15384/34397_B_9_1_rna_selected_60x60.jpg) | Group enriched |
MYL2 | Myosin, light chain 2, regulatory, cardiac, slow | Candidate cardiovascular disease genes Cytoskeleton related proteins Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39262/109226_B_9_3_rna_selected_60x60.jpg) | Group enriched |
MYL3 | Myosin, light chain 3, alkali; ventricular, skeletal, slow | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18662/43775_B_8_2_rna_selected_60x60.jpg) | Group enriched |
NPPA | Natriuretic peptide A | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58269/133551_B_8_7_rna_selected_60x60.jpg) | Tissue enriched |
ORM1 | Orosomucoid 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46438/103658_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
PAPPA | Pregnancy-associated plasma protein A, pappalysin 1 | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images/1667/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16724/37572_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
PDGFA | Platelet-derived growth factor alpha polypeptide | Cancer-related genes Candidate cardiovascular disease genes Predicted secreted proteins RAS pathway related proteins
| | ![](/images/5579/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/5579/19265_B_9_2_rna_selected_60x60.jpg) | Mixed |
PDGFB | Platelet-derived growth factor beta polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11972/28201_B_9_1_rna_selected_60x60.jpg) | Mixed |
PF4 | Platelet factor 4 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26008/63458_A_3_5_rna_selected_60x60.jpg) | Tissue enriched |
PGAM1 | Phosphoglycerate mutase 1 (brain) | Candidate cardiovascular disease genes Enzymes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49237/117897_A_7_2_rna_selected_60x60.jpg) | Expressed in all |
PLA2G1B | Phospholipase A2, group IB (pancreas) | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Predicted secreted proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images/60803/ihc_cell_selected_60x60.jpg) | ![](/images/60803/135493_A_2_5_rna_selected_60x60.jpg) | Tissue enriched |
PLG | Plasminogen | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/668/ihc_cell_selected_60x60.jpg) | ![](/images/668/1156_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
PON1 | Paraoxonase 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/1610/6963_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
PON2 | Paraoxonase 2 | Candidate cardiovascular disease genes Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/25430/54118_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
PON3 | Paraoxonase 3 | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images/14848/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14848/33300_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
PROC | Protein C (inactivator of coagulation factors Va and VIIIa) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5550/16154_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
PROCR | Protein C receptor, endothelial | Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | ![](/images/39461/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39461/82466_B_8_2_rna_selected_60x60.jpg) | Mixed |
PROS1 | Protein S (alpha) | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/23974/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/23974/53791_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
REN | Renin | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25903/56318_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes
| | | ![](/images/73/ihc_cell_selected_60x60.jpg) | ![](/images/73/1482_B_5_5_rna_selected_60x60.jpg) | Group enriched |
SELE | Selectin E | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/2143/ihc_cell_selected_60x60.jpg) | ![](/images/2143/6010_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/2144/ihc_cell_selected_60x60.jpg) | ![](/images/2144/5972_A_7_7_rna_selected_60x60.jpg) | Group enriched |
SELP | Selectin P (granule membrane protein 140kDa, antigen CD62) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/2145/5902_B_8_5_rna_selected_60x60.jpg) | Mixed |
SELPLG | Selectin P ligand | Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2431/6179_A_8_1_rna_selected_60x60.jpg) | Mixed |
SERPINA1 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/927/ihc_cell_selected_60x60.jpg) | ![](/images/927/2682_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
SERPINA3 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/893/ihc_cell_selected_60x60.jpg) | ![](/images/893/2299_B_8_7_rna_selected_60x60.jpg) | Tissue enriched |
SERPINA5 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images/56919/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/56919/129395_A_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
SERPINC1 | Serpin peptidase inhibitor, clade C (antithrombin), member 1 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24007/52473_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
SERPIND1 | Serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8639/21739_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
SERPING1 | Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26161/57861_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
TFPI | Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | Candidate cardiovascular disease genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images/20842/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/20842/46622_B_2_1_rna_selected_60x60.jpg) | Expressed in all |
TGFB1 | Transforming growth factor, beta 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images/47516/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/361/2838_B_7_6_rna_selected_60x60.jpg) | Expressed in all |
THBD | Thrombomodulin | Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2982/8442_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
THBS1 | Thrombospondin 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33678/85102_B_8_2_rna_selected_60x60.jpg) | Mixed |
TIMP1 | TIMP metallopeptidase inhibitor 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images/22360/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/22360/57604_B_9_6_rna_selected_60x60.jpg) | Expressed in all |
TNNI3 | Troponin I type 3 (cardiac) | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46428/142466_B_2_1_rna_selected_60x60.jpg) | Tissue enriched |
TNNT2 | Troponin T type 2 (cardiac) | Candidate cardiovascular disease genes Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15371/34257_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
TPM1 | Tropomyosin 1 (alpha) | Cancer-related genes Candidate cardiovascular disease genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9066/24147_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
VEGFA | Vascular endothelial growth factor A | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | ![](/images/5429/ihc_cell_selected_60x60.jpg) | ![](/images/5429/19719_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
VTN | Vitronectin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60933/144159_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
VWF | Von Willebrand factor | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images/1815/if_selected_60x60.jpg) | ![](/images/1815/ihc_cell_selected_60x60.jpg) | ![](/images/1815/6694_B_9_3_rna_selected_60x60.jpg) | Mixed |